Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved?

scientific article published on 14 May 2013

Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CNCR.28168
P698PubMed publication ID23674318

P2093author name stringJohn C Bailar
Kathryn Coe
G Marie Swanson
Kat Kwiatkowski
P2860cites workRace and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic reviewQ33300205
Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress?Q34684177
Selection and description of cancer clinical trials participants--science or happenstance?Q34810785
Reporting and representation of race/ethnicity in published randomized trialsQ39935914
Historical and current policy efforts to eliminate racial and ethnic health disparities in the United States: future opportunities for public health education researchQ40318230
Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusionQ45161542
Underrepresentation of patients 65 years of age or older in cancer-treatment trialsQ73311140
Participation in cancer clinical trials: race-, sex-, and age-based disparitiesQ80179103
Policies to reduce racial and ethnic disparities in child health and health careQ80571528
Black-White health disparities in the United States and Chicago: a 15-year progress analysisQ82282016
P433issue16
P407language of work or nameEnglishQ1860
P304page(s)2956-2963
P577publication date2013-05-14
P1433published inCancerQ326041
P1476titleInclusion of minorities and women in cancer clinical trials, a decade later: Have we improved?
P478volume119

Reverse relations

cites work (P2860)
Q41010687A Randomized Controlled Trial of Opt-In Versus Opt-Out Enrollment Into a Diabetes Behavioral Intervention.
Q52685422A novel approach for medical research on lymphomas: A study validation of claims-based algorithms to identify incident cases.
Q90371291AAN position statement: Ethical issues in clinical research in neurology
Q38373496Acceptance of Mobile Health in Communities Underrepresented in Biomedical Research: Barriers and Ethical Considerations for Scientists
Q41818553Adaptation of a Cancer Clinical Trials Education Program for African American and Latina/o Community Members.
Q38241955Adverse events in cancer patients with sickle cell trait or disease: case reports
Q34943392Attitudes toward molecular testing for personalized cancer therapy
Q37461392Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer
Q26768632Barriers to a cure for HIV in women
Q45073210Biospecimen donation among black and white breast cancer survivors: opportunities to promote precision medicine
Q58699631Cancer Health Literacy and Willingness to Participate in Cancer Research and Donate Bio-Specimens
Q35598300Cancer Research Participation Beliefs and Behaviors of a Southern Black Population: A Quantitative Analysis of the Role of Structural Factors in Cancer Research Participation.
Q99234116Cancer health disparities in racial/ethnic minorities in the United States
Q52802234Cohort Profile: The Haematological Malignancy Research Network (HMRN); a UK population-based patient cohort.
Q92615912Connecting Community to Research: A Training Program to Increase Community Engagement in Research
Q64109151Count me in: using a patient portal to minimize implicit bias in clinical research recruitment
Q53795716Cultural Connections: the Key to Retention of Black, Latina, and Arab Women in the Kin Keeper(SM) Cancer Prevention Intervention Studies.
Q37703002Culturally adapting a physical activity intervention for Somali women: the need for theory and innovation to promote equity
Q39463558Determining If Sex Bias Exists in Human Surgical Clinical Research
Q98186311Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process
Q89491824Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients
Q55510122Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials.
Q99236812Efficacy and safety of immune checkpoint blockade in self-identified black patients with advanced non-small cell lung cancer
Q88814369Empowering Latina breast cancer patients to make informed decisions about clinical trials: a pilot study
Q90282510Engaging Latina breast cancer survivors in research: building a social network research registry
Q35445265Evaluating a community-partnered cancer clinical trials pilot intervention with African American communities
Q36930276Exclusion of Women of Childbearing Potential in Clinical Trials of Type 2 Diabetes Medications: A Review of Protocol-Based Barriers to Enrollment.
Q47224501Gender differences in clinical registration trials; is there a real problem?
Q49966627Global geographical variation in patient characteristics in percutaneous coronary intervention clinical trials: A systematic review and meta-analysis.
Q33729072Hispanic accrual on randomized cancer clinical trials: a call to arms
Q42680523How will the 'cancer moonshot' impact health disparities?
Q48124116Improving the accrual of racial and ethnic minority patients in clinical trials: Time to raise the stakes.
Q53628105LGBTQ Health Surveillance: Data = Power.
Q35677959Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network
Q50905419Mexican-American perspectives on participation in clinical trials: A qualitative study.
Q97543409Missing diversity in brain tumor trials
Q35170581Motivators and barriers to Latinas' participation in clinical trials: the role of contextual factors.
Q91525021One and a half million medical papers reveal a link between author gender and attention to gender and sex analysis
Q30224492Participating in research: attitudes within the African American church
Q89139059Race-, Age-, and Gender-Based Characteristics and Toxicities of Targeted Therapies on Phase I Trials
Q49407879Reporting of sex and gender in randomized controlled trials in Canada: a cross-sectional methods study.
Q35226724Strategies addressing barriers to clinical trial enrollment of underrepresented populations: a systematic review.
Q54982900Temporal trends and characteristics of clinical trials for which only one racial or ethnic group is eligible.
Q26995858The impact of socioeconomic status on access to cancer clinical trials
Q40095262The role of functional, social, and mobility dynamics in facilitating older African Americans participation in clinical research
Q28550510Twenty years and still counting: including women as participants and studying sex and gender in biomedical research
Q39486611White-Black Differences in Cancer Incidence, Stage at Diagnosis, and Survival among Adults Aged 85 Years and Older in the United States

Search more.